Dezheng Huo to Hematologic Neoplasms
This is a "connection" page, showing publications Dezheng Huo has written about Hematologic Neoplasms.
Connection Strength
0.046
-
A phase I trial of gemcitabine plus cladribine in patients with advanced hematologic malignant diseases. Cancer Chemother Pharmacol. 2004 Dec; 54(6):553-61.
Score: 0.046
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.